The new machine integrates real-time surface-guided radiation therapy (SGRT) through IDENTIFY, allowing continuous monitoring of patient positioning during treatment
Medanta – The Medicity has launched Varian EDGE radiation therapy system, which for the first time comes integrated with IDENTIFY surface-guided technology, HyperArc, RapidArc Dynamic therapy, and functional SRS cones.
The next-generation radiation platform significantly reduces treatment time to nearly one minute per session for most cancers, while delivering sub-millimetric precision, enabling superior tumor targeting with minimal exposure to surrounding healthy tissue. This results in faster, safer, and more comfortable radiation therapy, even for complex and high-risk tumours.
Dr Naresh Trehan, Chairman and Managing Director, Medanta emphasised technology’s pivotal role in the hospital’s enduring commitment to delivering world-class, patient-centric care. He said, “Technology is driving a revolution in healthcare and its participation in the enhancement of medicine is a huge importance to humanity. We have opted for the latest equipment as we are steadfast in our commitment to deliver the best in healthcare, reflected in the Medanta ethos – ‘Har Ek Jaan Anmol’ (Every Life Is Invaluable).”
Dr Tejinder Kataria, Chairperson, Radiation Oncology, Cancer Care at Medanta –The Medicity said, “Designed to treat a broad spectrum of cancers — including multiple brain metastases, head and neck cancers, breast cancer, and lung cancer — this equipment enhances both clinical accuracy and patient experience, reinforcing Medanta’s commitment to world-class, patient-first oncology care.”
The new machine integrates real-time surface-guided radiation therapy (SGRT) through IDENTIFY, allowing continuous monitoring of patient positioning during treatment. This ensures immediate correction or the automatic cessation of radiation if the patient moves out of position. This enhances safety across all age groups, including paediatric patients. Importantly, patients of most cancers no longer require a thermoplastic cast, which is typically used to securely hold the patient in place during radiation treatment.
The new machine integrates real-time surface-guided radiation therapy (SGRT) through IDENTIFY, allowing continuous monitoring of patient positioning during treatment
Medanta – The Medicity has launched Varian EDGE radiation therapy system, which for the first time comes integrated with IDENTIFY surface-guided technology, HyperArc, RapidArc Dynamic therapy, and functional SRS cones.
The next-generation radiation platform significantly reduces treatment time to nearly one minute per session for most cancers, while delivering sub-millimetric precision, enabling superior tumor targeting with minimal exposure to surrounding healthy tissue. This results in faster, safer, and more comfortable radiation therapy, even for complex and high-risk tumours.
Dr Naresh Trehan, Chairman and Managing Director, Medanta emphasised technology’s pivotal role in the hospital’s enduring commitment to delivering world-class, patient-centric care. He said, “Technology is driving a revolution in healthcare and its participation in the enhancement of medicine is a huge importance to humanity. We have opted for the latest equipment as we are steadfast in our commitment to deliver the best in healthcare, reflected in the Medanta ethos – ‘Har Ek Jaan Anmol’ (Every Life Is Invaluable).”
Dr Tejinder Kataria, Chairperson, Radiation Oncology, Cancer Care at Medanta –The Medicity said, “Designed to treat a broad spectrum of cancers — including multiple brain metastases, head and neck cancers, breast cancer, and lung cancer — this equipment enhances both clinical accuracy and patient experience, reinforcing Medanta’s commitment to world-class, patient-first oncology care.”
The new machine integrates real-time surface-guided radiation therapy (SGRT) through IDENTIFY, allowing continuous monitoring of patient positioning during treatment. This ensures immediate correction or the automatic cessation of radiation if the patient moves out of position. This enhances safety across all age groups, including paediatric patients. Importantly, patients of most cancers no longer require a thermoplastic cast, which is typically used to securely hold the patient in place during radiation treatment.
